Defining the complementarities between antibodies and haptens to refine our understanding and aid the prediction of a successful binding interaction. (2015)
Attributed to:
LMC development for ExoMars
funded by
STFC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12896-015-0217-x
PubMed Identifier: 26498921
Publication URI: http://europepmc.org/abstract/MED/26498921
Type: Journal Article/Review
Volume: 15
Parent Publication: BMC biotechnology
ISSN: 1472-6750